Scott Carmer's most recent trade in Neximmune Inc was a trade of 7,058 Common Stock done . Disclosure was reported to the exchange on Feb. 17, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neximmune Inc | Scott Carmer | Director, President and CEO | 17 Feb 2021 | 7,058 | 7,058 | - | - | Common Stock | ||
| Neximmune Inc | Scott Carmer | Director, President and CEO | 17 Feb 2021 | 7,058 | 0 | - | - | Series A Preferred Stock | ||
| Neximmune Inc | Scott Carmer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 306,842 | 770,923 | - | - | Stock Option (right to buy) |